HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tinghao Li Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

12/2023SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy.
4/2023YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1-RPN2-PI3K/AKT/mTOR Axis.
10/2022EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation.
11/2021SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis.
1/2021An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
1/2020Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-β Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tinghao Li Research Topics

Disease

6Urinary Bladder Neoplasms (Bladder Cancer)
12/2023 - 01/2020
6Neoplasms (Cancer)
04/2023 - 11/2020
2Prostatic Neoplasms (Prostate Cancer)
03/2022 - 11/2020
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2020
2Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2021
1Carcinogenesis
04/2023
1Melanoma (Melanoma, Malignant)
08/2022
1Starvation
11/2021
1Lung Neoplasms (Lung Cancer)
11/2021
1Breast Neoplasms (Breast Cancer)
11/2021
1Colorectal Neoplasms (Colorectal Cancer)
11/2021
1Metabolic Diseases (Metabolic Disease)
01/2021

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
04/2023 - 01/2020
3Cisplatin (Platino)FDA LinkGeneric
12/2023 - 11/2021
3RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
3Long Noncoding RNAIBA
01/2021 - 01/2021
2Messenger RNA (mRNA)IBA
04/2023 - 03/2022
1Beclin-1IBA
12/2023
1Sirtuin 1IBA
12/2023
16-methyladenineIBA
04/2023
1N-methyladenosineIBA
04/2023
1Epidermal Growth Factor (EGF)IBA
10/2022
1Carrier Proteins (Binding Protein)IBA
10/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2022
1Antisense RNA (Anti-Sense RNA)IBA
08/2022
1Ubiquitin-Specific ProteasesIBA
08/2022
1Docetaxel (Taxotere)FDA Link
03/2022
1eIF-4BIBA
03/2022
1Factor X (Stuart Factor)IBA
03/2022
1Hormones (Hormone)IBA
03/2022
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1CateninsIBA
11/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1740Y-PIBA
11/2020
1Cysteine Proteinase InhibitorsIBA
11/2020
1Fetuin-BIBA
11/2020
1Glycoproteins (Glycoprotein)IBA
11/2020
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2020
1VimentinIBA
01/2020
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2020
16- (2- tert- butyl- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 4- yl)quinoxalineIBA
01/2020

Therapy/Procedure

1Castration
03/2022
1Drug Therapy (Chemotherapy)
11/2021